The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 03, 2024

Filed:

Dec. 04, 2020
Applicant:

University of Sharjah, Sharjah, AE;

Inventors:

Taleb H. Altel, Sharjah, AE;

Raafat A El-Awady, Sharjah, AE;

Srinivasulu Vunnam, Sharjah, AE;

Cijo George Vazhappilly, Sharjah, AE;

Hany A. Omar, Sharjah, AE;

Assignee:

UNIVERSITY OF SHARJAH, Sharjah, AE;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 513/14 (2006.01); A61P 35/00 (2006.01); C07D 471/14 (2006.01); C07D 471/22 (2006.01); C07D 491/147 (2006.01); C07D 513/22 (2006.01);
U.S. Cl.
CPC ...
C07D 513/14 (2013.01); A61P 35/00 (2018.01); C07D 471/14 (2013.01); C07D 471/22 (2013.01); C07D 491/147 (2013.01); C07D 513/22 (2013.01);
Abstract

A compound represented by following formula I: according to the present disclosure. The disclosed compound is useful in the treatment of many disease states related to cell proliferation. In particular, new pyran derivatives are provided along with processes for preparations and methods for pharmaceutical applications, for example, as anticancer agents. The compound was found to have antiproliferative effects against multiple cancer cell lines and showed low toxicity to normal fibroblasts. The disclosed compound also exhibited anticancer properties by inducing caspase-mediated cell death mechanisms and arresting cancer cell progression. Further, the compound represented by Formula I targets multiple key proteins/enzymes, including thioredoxin reductase, glutathione reductase, transferrin receptors, inisitol-3-phosphate synthase, cystolic aminopeptidase, and transketolase, which are over-expressed in tumor cells.


Find Patent Forward Citations

Loading…